Soligenix Inc

Research Soligenix Inc (SNGX) on Bullrun: market cap USD 5.93M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSNGX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 5.93M
• Financial periodFY2025
• Net income-USD 11.08M
• Free cash flow-USD 10.27M

Valuation Snapshot

latest market cap is USD 5.93M.

About Soligenix Inc

Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. The company operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a photodynamic therapy, which has completed Phase 3 clinical trial for the treatment of cutaneous T-cell lymphoma;

Frequently asked questions

What is Soligenix Inc's market cap?

Soligenix Inc's market capitalization is USD 5.93M.

What does Soligenix Inc do?

Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. The company operates through two segments, Specialized BioTherapeutics and Public Health Solutions.